The FDA announced it will likely approve fall Covid-19 booster shots for adults over 65 and those with underlying health conditions. However, additional studies are needed before approving vaccines for healthy younger adults. FDA officials cited uncertain benefits for this group in The New England Journal of Medicine. A decision on the fall vaccine composition will be made Thursday by scientific advisors.

Prepared by Olivia Bennett and reviewed by editorial team.